Mitsubishi Tanabe Pharma Corporation

Notes

• Figures in ¥ billions
• Financial data sourced from official Japanese regulatory disclosures
• Each column header links to its source filing; select a line to see its XBRL elements.
• Each year is shown as filed in that year's own report. Switch to Restated to see a year as the next year's report restated it; restated cells are marked R.
• Displaying 3 of 3 periods
• YoY Change compares each period with the same period a year earlier. A full year's change uses the prior year as that year's own report restates it (cells marked R), so it can differ from the change between the two columns as filed.
• Columns marked “Summary only”: for these years the filing tags only its summary of key figures (主要な経営指標等) in machine-readable form, as is usual for US-GAAP filers, so line items such as operating income are not available. The figures shown are the company’s own consolidated totals.
• FY = fiscal year, named by the calendar year it starts in; the month in brackets is when it ends (FY2025 ends Mar 2026 for a March year-end). FY2018 (Mar 2019) runs Apr 1, 2018 – Mar 31, 2019.